Former GN chair says there have been no acquisition signs from Demant owner
Per Wold-Olsen left the chairperson position two weeks ago after 15 years – he now reveals there haven’t been acquisition talks behind closed doors during his time at the company.
by christopher due karlsson, translated by daniel pedersen
The board of directors at GN Group have not seen any indications from major stockholder William Demant Invest, the investment company of Demant-owner the William Demant Foundation, about a potential acquisition of the hearing company, says former chairman Per Wold-Olsen to MedWatch.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
JPMorgan says GN prognosis is too "conservative"
For subscribers
William Demant Invest report reveals GN Group stake
For subscribers
